Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-01-12 @ 3:30 AM
Study NCT ID:
NCT00673205
Status:
COMPLETED
Last Update Posted:
2010-12-10
First Post:
2008-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D6876C00024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Tom Morris
Old Organization:
AstraZeneca Pharmaceuticals